COUNT XI District of Columbia False Claims Act
C. Code §2-30S.03 et seq. (Against All Defendants)
Plaintiffs reallege and incorporate by reference Paragraphs 1-261 set forth above.
This Count is brought by Lisitza in the name of the District of Columbia under the
qui tam provisious of D.C. Code §2-308.03 et seq.
pharmaceuticals in the District of Columbia. Omnicare, at all times relevant to this action, has
operated and continues to operate pharmacies in the District of Columbia.
action, sold and continue to sell pharmaceuticals in the District of Columbia.
Manufacturers Bristol Myers, Janssen, Ortho McNeil and Pfizer knowingly caused false claims
for payment or approval, in the form of false cost information for their "preferred" medications
specified herein, as well as other medications manufactured by them, to be presented to officers
governments paid reimbursements for the Defendant Manufacturers' drugs to Omnicare and
other Medicaid provider pharmacies sums of money grossly in excess of the amounts
contemplated by law, resulting in great financial loss to the federal and state
knowingly caused to be presented false or fraudulent claims for payment or approval, and
possibly continues to cause to be submitted false or fraudulent claims for payment or approval,
directly or indirectly, to officers, employees, or agents of the District of Columbia, for Monopril,
Abilify, and other drugs.